Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: not including (1000), without (1000)

Opt out of research

Description: Auto Generated Title While most of our research is done on an opt in basis, participants also have the opportunity t
Url: /ClinicalResearchinSouthampton/Public-and-patients/Opt-out-of-research.aspx

NIHR expression of interest

Description: NIHR CRN Site Identification Support Expression of Interest (EOI) Guidance (v2 May 2018) The expression of interest process is intended to
Url: /Media/Southampton-Clinical-Research/NIHR-expression-of-interest.pdf

Meningitis trial_frequently asked questions

Description: F.A.Q.: Human nasopharyngeal colonization using a genetically modified strain of the bacteria, Neisseria lactamica This document contains information and
Url: /Media/Southampton-Clinical-Research/Researchtrials/Meningitis-trial-frequently-asked-questions.pdf

Rehab directory submissions

Description: Organisation Dorset Brain Injury Service Contact Name John Burn Email Address John.burn@poole.nhs.uk Telephone 01202448070 Website Addre
Url: /Media/SUHTExtranet/WessexTraumaNetwork/Rehab-directory-submissions.pdf

A guide to your child's CADD pump - patient information

Description: This factsheet explains what a computerised ambulatory delivery device (CADD) pump is, how it works and how to use it safely
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/A-guide-to-your-childs-CADD-pump-3793-PIL.pdf

InP RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVE) Inpatient Regimen Regimen Lymphoma – InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab.pdf

Radioactive iodine treatment for thyroid cancer - patient information

Description: This factsheet explains what radioactive iodine (RAI) treatment for thyroid cancer is and what the treatment involves, so you know what
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Radioactive-iodine-treatment-for-thyroid-cancer-3871-PIL.pdf

Cemiplimab

Description: Chemotherapy Protocol SKIN CANCER Cemiplimab (350mg) Regimen  Skin – Cemiplimab (350mg) Indication  Metastatic or locally advanced cutaneous squamous cell carcinoma in patients
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Cemiplimab.pdf

UHS Patient safety incident response plan

Description: Patient safety incident response plan Effective date: 2nd October 2023 Estimated refresh date:2nd October 2024 with informal review after the
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Patient-safety-incident-response-plan.pdf

InP (RICE) Carboplatin Etoposide Ifosfamide Rituximab

Description: Chemotherapy Protocol LYMPHOMA CARBOPLATIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RICE) Inpatient Regimen Regimen • Lymphoma – InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RICE-Carboplatin-Etoposide-Ifosfamide-Rituximab.pdf

141 to 150 of 249

Previous … 13 14 15 16 17 … Next